Genetic differences in Native Americans and tacrolimus dosing after kidney transplantation

Transplantation Proceedings

Volumn 45, Issue 1, 2013, Pages 137-141

  Chakkera, H A ^a   Chang, Y H ^b   Bodner, J K ^a   Behmen, S ^a   Heilman, R L ^a   Reddy, K S ^b   Mulligan, D C ^b   Moss, A A ^b   Khamash, H ^a   Katariya, N ^b   Hewitt, W R ^b   Pitta, T L ^b   Frassetto, L A ^c  

^a MAYO CLINIC HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; MULTIDRUG RESISTANCE PROTEIN 1; TACROLIMUS;

ADULT; AMERICAN INDIAN; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC DIFFERENCE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; PHARMACOGENETICS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; COHORT STUDIES; FEMALE; GENETIC VARIATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDIANS, NORTH AMERICAN; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; P-GLYCOPROTEIN; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; TACROLIMUS; TIME FACTORS;

EID: 84873281407     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.10.023     Document Type: Article

References (17)

1. M.R. First Tacrolimus based immunosuppression J Nephrol 17 suppl 8 2004 S25 S31
2. S. Masuda, K. Inui An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients Pharmacol Ther 112 2006 184 198
3. C.E. Staatz, S.E. Tett Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation Clin Pharmacokinet 43 2004 623 653
4. P.A. Andrews, M. Sen, R.W. Chang Racial variation in dosage requirements of tacrolimus Lancet 348 1996 1446
5. J.F. Neylan Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine FK506 Kidney Transplant Study Group Transplantation 65 1998 515 523
6. A. Grover, L.A. Frassetto, L.Z. Benet Pharmacokinetic differences corroborate observed low tacrolimus dosage in Native American renal transplant patients Drug metabolism and disposition: the biological fate of chemicals 39 2011 2017 2019
7. I.A. Macphee, S. Fredericks, T. Tai Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement Transplantation 74 2002 1486 1489
8. D. Anglicheau, E. Thervet, I. Etienne CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation Clin Pharmacol Ther 75 2004 422 433
9. I. Ieiri, S. Higuchi, Y. Sugiyama Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs Expert Opin Drug Metab Toxicol 5 2009 703 729
10. A. Pawarode, S. Shukla, H. Minderman Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins Cancer Chemother Pharmacol 60 2007 179 188
11. C.Y. Cheung, R.A. Op den Buijsch, K.M. Wong Influence of different allelic variants of the CYP3A and ABCB1 genes on the tacrolimus pharmacokinetic profile of Chinese renal transplant recipients Pharmacogenomics 7 2006 563 574
12. R.B. Kim, B.F. Leake, E.F. Choo Identification of functionally variant MDR1 alleles among European Americans and African Americans Clin Pharmacol Ther 70 2001 189 199
13. M. Tanabe, I. Ieiri, N. Nagata Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene J Pharmacol Exp Ther 297 2001 1137 1143
14. Division of Clinical Pharmacology Indiana University School of Medicine P450 Drug Interaction Table http://medicine.iupui.edu/clinpharm/ddis/table.aspx Accessed April 4, 2009
15. F.G. Cosio, J.P. Grande, T.S. Larson Kidney allograft fibrosis and atrophy early after living donor transplantation Am J Transplant 5 2005 1130 1136
16. R.L. Heilman, Y. Devarapalli, H.A. Chakkera Impact of subclinical inflammation on the development of interstitial fibrosis and tubular atrophy in kidney transplant recipients Am J Transplant 10 2010 563 570
17. C.E. Staatz, C. Willis, P.J. Taylor Population pharmacokinetics of tacrolimus in adult kidney transplant recipients Clin Pharmacol Ther 72 2002 660 669